Regulus Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Regulus Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Regulus Therapeutics filed an 8-K, check for updates.
AI Summary
Regulus Therapeutics Inc. filed an 8-K on March 27, 2025, reporting on other events and financial statements. The filing does not contain specific details about new agreements, material events, or financial figures within the provided text.
Why It Matters
This 8-K filing indicates Regulus Therapeutics Inc. is providing updates to the SEC, which could include material information relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial or operational details that would indicate high risk.
Key Players & Entities
- Regulus Therapeutics Inc. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-35670 (identifier) — Commission File Number
- 26-4738379 (identifier) — IRS Employer Identification No.
- 4224 Campus Point Court, Suite 210 (address) — Address of principal executive offices
- San Diego, CA 92121 (address) — City, State, Zip of principal executive offices
- (858) 202-6300 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on Other Events and Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 27, 2025.
In which state was Regulus Therapeutics Inc. incorporated?
Regulus Therapeutics Inc. was incorporated in Delaware.
What is the principal executive office address for Regulus Therapeutics Inc.?
The principal executive offices are located at 4224 Campus Point Court, Suite 210, San Diego, CA 92121.
What is the Commission File Number for Regulus Therapeutics Inc.?
The Commission File Number for Regulus Therapeutics Inc. is 001-35670.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Regulus Therapeutics Inc..